Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Spiriva HandiHaler, tiotropium
print preview
bookmark
share with colleague
General Information
Company
Boehringer Ingelheim GmbH
Description
Once-daily inhaled bronchodilator delivered via a propellant-free breath actuated dry powder inhaler
Molecular Target
Muscarinic acetylcholine receptor M3 (CHRM3) (HM3)
Mechanism of Action
Muscarinic acetylcholine receptor M3 antagonist
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy